Use of fluoroquinolones was associated with a 2.5-fold increase in risk of hospitalization for aortic aneurysm or aortic dissection.

Among patients with cardiogenic shock secondary to acute myocardial infarction (AMI), epinephrine led to a significantly increased rate of refractory shock compared to norepinephrine.

Nasally administered etripamil was more effective than placebo at converting SVT to normal sinus rhythm and is now moving on to phase 3 trials.  Stay tuned.

Use of a rapid rule-out MI protocol with hs-cTnT was safe, accurate, and would have reduced time to discharge and increased the proportion of patients ruled out in this U.S.-based implementation study.

Self-referral for elevated blood pressure after using a home or pharmacy cuff had a very low admission rate at 3%.

A low daily dose of aspirin (75-100mg) prevents cardiovascular events only in patients weighing < 70 kg. Higher doses are required in patients weighing more.

Among patients with atrial fibrillation with rapid ventricular response, low-dose magnesium (4.5g over 30 minutes) is an effective adjunct to standard therapy compared to placebo and causes far fewer side effects than high dose magnesium.

For patients with high pretest probability for pulmonary embolism, a negative CT pulmonary angiography alone does not appear to adequately rule out venous thromboembolism.

JAMA recently covered infective endocarditis (IE).  I thought the JF readers would be well served by a Spoon Feed version.  This thing is 12 pages long with 117 references.  Let's miniaturize it, shall we?

Patients with cardiovascular disease and concomitant COPD can be safely treated with a combination long-acting beta-agonist and a long-acting muscarinic antagonist when on a baseline beta-blocker.